Salivary oxidative stress in oral lichen planus treated with triamcinolone mouthrinse
- PMID: 28584533
- PMCID: PMC5443004
Salivary oxidative stress in oral lichen planus treated with triamcinolone mouthrinse
Abstract
Background: Total antioxidant capacity (TAC) and malondialdehyde (MDA) levels have not been reported in oral lichen planus (OLP) patients treated with a topical corticosteroid. This study evaluates TAC and MDA levels in unstimulated saliva of OLP patients. Such measurements may need to be supported by clinical observation.
Materials and methods: Twenty patients with OLP participated in a study conducted at the Department of Oral Medicine, Tehran University of Medical Sciences. Salivary TAC and MDA were determined by biochemical analyses before and after 5-week triamcinolone acetonide (0.2%) mouthrinse treatment. Subjective symptoms as well as lesion status pre- and post-treatment were measured using visual analog scale (VAS) and clinical scoring system, respectively. Wilcoxon signed rank test was used for the evaluation of MDA and TAC parameters, VASs, and rates of clinical scores. Spearman's rank correlation was used to determine the relationship between different variables.
Results: A statistically significant increase in salivary TAC was found after treatment. There was no significant difference in the reduction of salivary MDA levels in OLP patients after treatment.
Conclusion: Posttreatment analyses revealed a significant degree of recovery and pain relief of OLP lesions. Hence, triamcinolon mouthrinse by reducing oxidative stress is an appropriate treatment in OLP patients.
Keywords: Malondialdehyde; oral lichen planus; oxidative stress; triamcinolone acetonide.
Conflict of interest statement
The authors of this manuscript declare that they have no conflicts of interest, real or perceived, financial or nonfinancial, in this article.
Figures


Similar articles
-
Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma.J Oral Pathol Med. 2012 Nov;41(10):736-40. doi: 10.1111/j.1600-0714.2012.01172.x. Epub 2012 May 15. J Oral Pathol Med. 2012. PMID: 22582895
-
Clinical and biochemical assessment of the effect of topical use of coenzyme Q10 versus topical corticosteroid in management of symptomatic oral lichen planus: randomized controlled clinical trial.BMC Oral Health. 2023 Jul 21;23(1):506. doi: 10.1186/s12903-023-03206-5. BMC Oral Health. 2023. PMID: 37480004 Free PMC article. Clinical Trial.
-
Evaluation of prolidase activity and oxidative stress in patients with oral lichen planus and oral lichenoid contact reactions.J Oral Pathol Med. 2016 Apr;45(4):281-8. doi: 10.1111/jop.12391. Epub 2015 Dec 14. J Oral Pathol Med. 2016. PMID: 26661727
-
Systematic Review and Meta-Analysis of Oxidative Stress and Antioxidant Markers in Oral Lichen Planus.Oxid Med Cell Longev. 2021 Sep 27;2021:9914652. doi: 10.1155/2021/9914652. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34616506 Free PMC article.
-
A systematic review and meta-analysis on serum and salivary levels of total antioxidant capacity and C-reactive protein in oral lichen planus patients.Arch Oral Biol. 2022 Aug;140:105445. doi: 10.1016/j.archoralbio.2022.105445. Epub 2022 May 10. Arch Oral Biol. 2022. PMID: 35623114
Cited by
-
Patch test of dental materials in Oral Lichen Planus with considering the role of saliva.Sci Rep. 2021 Apr 15;11(1):8264. doi: 10.1038/s41598-021-87778-8. Sci Rep. 2021. PMID: 33859299 Free PMC article.
-
Effects of Photodynamic Therapy and Glucocorticosteroids on Salivary Oxidative Stress in Oral Lichen Planus: A Randomized Clinical Trial.Antioxidants (Basel). 2025 Aug 20;14(8):1017. doi: 10.3390/antiox14081017. Antioxidants (Basel). 2025. PMID: 40867913 Free PMC article.
References
-
- Agha-Hosseini F, Mirzaii-Dizgah I, Farmanbar N, Abdollahi M. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma. J Oral Pathol Med. 2012;41:736–40. - PubMed
-
- van der Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal. 2009;14:E310–4. - PubMed
-
- van der Meij EH, Schepman KP, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: A prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:164–71. - PubMed
-
- Gorsky M, Epstein JB. Oral lichen planus: Malignant transformation and human papilloma virus: A review of potential clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:461–4. - PubMed
-
- Arana C, Cutando A, Ferrera MJ, Gómez-Moreno G, Worf CV, Bolaños MJ, et al. Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients. J Oral Pathol Med. 2006;35:554–9. - PubMed
LinkOut - more resources
Full Text Sources